JP2020531526A5 - - Google Patents
Info
- Publication number
- JP2020531526A5 JP2020531526A5 JP2020511322A JP2020511322A JP2020531526A5 JP 2020531526 A5 JP2020531526 A5 JP 2020531526A5 JP 2020511322 A JP2020511322 A JP 2020511322A JP 2020511322 A JP2020511322 A JP 2020511322A JP 2020531526 A5 JP2020531526 A5 JP 2020531526A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- trisubstituted
- disubstituted
- unsubstituted
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17187100.7 | 2017-08-21 | ||
| EP17187100 | 2017-08-21 | ||
| PCT/EP2018/072397 WO2019038214A1 (en) | 2017-08-21 | 2018-08-20 | QUINOXALINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531526A JP2020531526A (ja) | 2020-11-05 |
| JP2020531526A5 true JP2020531526A5 (enExample) | 2023-02-02 |
| JP7287951B2 JP7287951B2 (ja) | 2023-06-06 |
Family
ID=59677147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511322A Active JP7287951B2 (ja) | 2017-08-21 | 2018-08-20 | アデノシン受容体アンタゴニストとしてのキノキサリン誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11192899B2 (enExample) |
| EP (1) | EP3672951B1 (enExample) |
| JP (1) | JP7287951B2 (enExample) |
| KR (1) | KR20200043434A (enExample) |
| CN (1) | CN110944994B (enExample) |
| AU (1) | AU2018320672B2 (enExample) |
| BR (1) | BR112020003283A2 (enExample) |
| CA (1) | CA3073343A1 (enExample) |
| DK (1) | DK3672951T3 (enExample) |
| ES (1) | ES2964026T3 (enExample) |
| IL (1) | IL272638B2 (enExample) |
| SG (1) | SG11202001340VA (enExample) |
| TW (1) | TW201920123A (enExample) |
| WO (1) | WO2019038214A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020182929A1 (en) | 2019-03-13 | 2020-09-17 | Bayer Aktiengesellschaft | Substituted ureas and derivatives as new antifungal agents |
| CN113646313B (zh) * | 2019-03-28 | 2023-05-30 | 基石药业（苏州）有限公司 | 一种a2a受体拮抗剂的盐型、晶型及其制备方法 |
| US20230339936A1 (en) * | 2020-07-23 | 2023-10-26 | Cytosinlab Therapeutics Co. Ltd. | Compound having kinase inhibitory activity |
| WO2022058327A1 (en) | 2020-09-15 | 2022-03-24 | Bayer Aktiengesellschaft | Substituted ureas and derivatives as new antifungal agents |
| US20220127231A1 (en) * | 2020-10-27 | 2022-04-28 | Shilpa Medicare Ltd | Process for the prepartion of amifampridine phosphate |
| EP4059498A1 (en) * | 2021-03-16 | 2022-09-21 | Centre Hospitalier Universitaire Vaudois (CHUV) | Methods and compositions for treating conditions associated with hypermineralization |
| EP4351640A1 (en) | 2021-06-07 | 2024-04-17 | Ares Trading S.A. | Combination treatment of cancer |
| CN116514803A (zh) * | 2022-01-21 | 2023-08-01 | 上海赛岚生物科技有限公司 | 一种激酶抑制剂的盐晶型和自由碱晶型 |
| CN121270522B (zh) * | 2025-12-10 | 2026-03-17 | 四川大学华西医院 | 吲唑-苯并三唑-吡唑结构衍生物及其制备方法和应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207554A (en) | 1972-08-04 | 1980-06-10 | Med-El Inc. | Method and apparatus for automated classification and analysis of cells |
| US4125828A (en) | 1972-08-04 | 1978-11-14 | Med-El Inc. | Method and apparatus for automated classification and analysis of cells |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| DE69720965T2 (de) | 1996-02-13 | 2004-02-05 | Astrazeneca Ab | Chinazolinderivate und deren verwendung als vegf hemmer |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| AU1688599A (en) | 1998-01-05 | 1999-07-26 | Eisai Co. Ltd. | Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| US6841549B1 (en) | 1999-07-02 | 2005-01-11 | Eisai Co., Ltd. | Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| AU2001258628A1 (en) | 2000-05-31 | 2001-12-11 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| MXPA02012903A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como inhibidores de angiogenesis. |
| MXPA02012905A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como agentes de dano vascular.. |
| WO2004089942A2 (en) | 2001-10-02 | 2004-10-21 | Acadia Pharmaceuticals Inc. | Benzimidazolidinone derivatives as muscarinic agents |
| EP1465634B1 (en) | 2001-12-12 | 2014-10-22 | The Government of the United States of America, as represented by the Secretary Department of Health and Human Services | Methods for using adenosine receptor inhibitors to enhance immune response and inflammation |
| US20080070932A1 (en) | 2003-04-09 | 2008-03-20 | Chi Vu | Triazolo[ 1,5-A] Pyrimidines And Pyrazolo[ 1,5-A] Pyrimidines And Methods Of Making And Using The Same |
| PT1636223E (pt) * | 2003-05-19 | 2008-05-06 | F Hoffmann-La Roche Ag | Derivados de benzotiazole como ligandos de receptores da adenosina |
| RU2006112847A (ru) | 2003-09-19 | 2007-11-10 | Ф. Хоффманн-Ля Рош Аг (Ch) | Производные тиазолопиридина в качестве лигандов аденозинового рецептора |
| JP2005154434A (ja) * | 2003-11-05 | 2005-06-16 | Kyowa Hakko Kogyo Co Ltd | ２−アミノキナゾリン誘導体 |
| RS50574B (sr) * | 2004-05-24 | 2010-05-07 | F. Hoffmann-La Roche Ag. | (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid 4-hidroksi-4-metil-piperidin-1-karboksilne kiseline |
| JP5202946B2 (ja) | 2004-07-22 | 2013-06-05 | エフ．ホフマン−ラ ロシュ アーゲー | ベンゾチアゾール誘導体 |
| EP2282999B1 (en) | 2008-03-04 | 2014-05-21 | Merck Sharp & Dohme Corp. | Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
-
2018
- 2018-08-20 EP EP18753208.0A patent/EP3672951B1/en active Active
- 2018-08-20 DK DK18753208.0T patent/DK3672951T3/da active
- 2018-08-20 KR KR1020207008007A patent/KR20200043434A/ko not_active Abandoned
- 2018-08-20 CN CN201880054521.1A patent/CN110944994B/zh active Active
- 2018-08-20 US US16/640,526 patent/US11192899B2/en active Active
- 2018-08-20 TW TW107128914A patent/TW201920123A/zh unknown
- 2018-08-20 SG SG11202001340VA patent/SG11202001340VA/en unknown
- 2018-08-20 BR BR112020003283-2A patent/BR112020003283A2/pt not_active Application Discontinuation
- 2018-08-20 WO PCT/EP2018/072397 patent/WO2019038214A1/en not_active Ceased
- 2018-08-20 AU AU2018320672A patent/AU2018320672B2/en not_active Ceased
- 2018-08-20 CA CA3073343A patent/CA3073343A1/en active Pending
- 2018-08-20 JP JP2020511322A patent/JP7287951B2/ja active Active
- 2018-08-20 IL IL272638A patent/IL272638B2/en unknown
- 2018-08-20 ES ES18753208T patent/ES2964026T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020531531A5 (enExample) | ||
| JP2020531526A5 (enExample) | ||
| RU2506256C2 (ru) | Лиганды для визуализации иннервации сердца | |
| JP2022524914A5 (enExample) | ||
| JP2020528922A5 (enExample) | ||
| CA2324418A1 (en) | Novel opiate compounds, methods of making and methods of use | |
| JP2019104748A5 (enExample) | ||
| RU99128073A (ru) | Замещенные 2-(2,6-диоксопиперидин-3-ил)-фталимиды и -1-оксоизоиндолины и способ снижения уровней фноа | |
| KR830007624A (ko) | 헤테로 사이클릭 화합물의 제조방법 | |
| JP2023504542A5 (enExample) | ||
| CA2457054A1 (en) | Activator of peroxisome proliferator-activated receptor .delta. | |
| RU2012143212A (ru) | Способ лечения артрита | |
| JP2002531564A5 (enExample) | ||
| DK191186A (da) | Indolderivater | |
| KR870011129A (ko) | 디스타마이신 a 동족체 및 이의 제조방법 | |
| EA200970171A1 (ru) | Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
| JP2005509735A5 (enExample) | ||
| JP2004525174A5 (enExample) | ||
| GB1046506A (en) | Guanidine compounds and process for their manufacture | |
| EP0092158A3 (en) | Thiazolidine compound and fungicidal composition containing it | |
| RU92016214A (ru) | Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов, способ их получения, фунгицидный состав на их основе и способ обработки культур | |
| MX2024008480A (es) | Compuesto heterociclico que contiene nitrogeno que tiene un efecto de activacion del factor 2 relacionado con el factor nuclear eritroide 2 (nrf2). | |
| JP2025160251A5 (enExample) | ||
| RU2008119994A (ru) | Ингибиторы калиевых каналов | |
| JP2023506005A5 (enExample) |